-
JBCRG-M02
Study of letrozole in postmenopausal patients with breast cancer - exploratory research on expression of hormone receptors and its clinical effect -
- Status
-
Study Closed
- Objectives
-
To evaluate the efficacy and safety of letrozole in postmenopausal patients with metastatic or locally advanced breast cancer
- Subjects
-
- Endpoints
-
Primary endpoint: Clinical response rate by hormone receptor status (Allred score) and Her2 status, Secondary endpoints: Time to progression, advertse events, expression of hormone receptor-related factors
- Trial Period
-
November 2006 - December 2012 (Registration: 2 years, Follow-up study: 2 years)
- Lead Principal Investigator
-
Katsumasa Kuroi (Department of Surgery / Division of Clinical trial and reseach, Metroplitan Komagome Hospital)
- Target Sample Size
-
50
- Regimen
-
Letrozole
- Source of Funding
-
Japan Breast Cancer Research Group (JBCRG)
- Conference Presentation
-
- Articles and Publications
-
- UMIN-ID
-
UMIN000000563
- jRCT
-
- Memo
-
- COI Disclosure
-
